Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol

Krishna Rao Sathya; Indu Sabu; Banamali Das; Mrutymjaya Rao Meda; Madan Mohan Padhi; Pragatheeswari Gurusamy; Gurucharan Bhuyan

doi:10.5455/jrtm.2026-308189

2026, Vol: 12, Issue: 1

Current Issue

Indexing

« Previous Article

Study Protocol
Online Published: 23 Jul 2026

J. res. tradit. med. 2026; 12(1): 158-164

doi: 10.5455/jrtm.2026-308189

Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol

Krishna Rao Sathya, Indu Sabu, Banamali Das, Mrutymjaya Rao Meda, Madan Mohan Padhi, Pragatheeswari Gurusamy, Gurucharan Bhuyan.

Abstract
Background: Allergic Rhinitis (AR) can be associated with Vataja Pratishyaya in Ayurveda and affects 20–30% of the Indian population, significantly impairing quality of life. While conventional management usually involves avoiding allergens, antiinflammatories, and antihistamines, Ayurveda offers immunomodulatory and local therapies. Objective: To evaluate and compare the efficacy of oral Haridrakhanda alone versus oral Haridrakhanda administered in combination with Anu Taila Nasya (nasal instillation) in alleviating the clinical symptoms and immunological markers of Allergic Rhinitis. Methods:This randomised, controlled, parallel-group clinical trial will recruit 144 eligible participants (aged 18–60) with a Total Nasal Symptom Score (TNSS) ≥6. Participants will be randomised into two groups of 72. Group A will receive Haridrakhanda (6g twice daily) orally, and Group B will receive oral Haridrakhanda (same dosage) combined with Anu Taila Nasya (2 drops per nostril daily) for 28 days. The efficacy of the trial will be assessed using TNSS as the primary outcome, with Serum IgE and Absolute Eosinophil Count (AEC) as secondary outcomes. Assessments will occur at baseline, day 28 (end of treatment), and day 56 (follow-up). Expected Outcomes: Data will be analysed using t-tests or Mann–Whitney U tests for continuous variables. The study anticipates that the dual approach (Group B), will demonstrate superior efficacy in reducing the symptoms of AR and immunological markers compared to oral therapy alone. Conclusion: This trial seeks to validate a synergistic Ayurvedic protocol for AR. If successful, it will provide evidence for an integrative management strategy addressing both Doshic imbalance and mucosal hypersensitivity.

Key words: Allergic Rhinitis, Ayurveda, Pratishyaya, Haridrakhanda, Anu Taila, Nasya.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Krishna Rao Sathya Articles by Indu Sabu Articles by Banamali Das Articles by Mrutymjaya Rao Meda Articles by Madan Mohan Padhi Articles by Pragatheeswari Gurusamy Articles by Gurucharan Bhuyan
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Sathya KR, Sabu I, Das B, Meda MR, Padhi MM, Gurusamy P, Bhuyan G. Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. J. res. tradit. med. 2026; 12(1): 158-164. doi:10.5455/jrtm.2026-308189

Web Style

Sathya KR, Sabu I, Das B, Meda MR, Padhi MM, Gurusamy P, Bhuyan G. Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. https://www.tmjournal.org/?mno=308189 [Access: October 10, 2026]. doi:10.5455/jrtm.2026-308189

AMA (American Medical Association) Style

Sathya KR, Sabu I, Das B, Meda MR, Padhi MM, Gurusamy P, Bhuyan G. Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. J. res. tradit. med. 2026; 12(1): 158-164. doi:10.5455/jrtm.2026-308189

Vancouver/ICMJE Style

Sathya KR, Sabu I, Das B, Meda MR, Padhi MM, Gurusamy P, Bhuyan G. Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. J. res. tradit. med. (2026), [cited October 10, 2026]; 12(1): 158-164. doi:10.5455/jrtm.2026-308189

Harvard Style

Sathya, K. R., Sabu, . I., Das, . B., Meda, . M. R., Padhi, . M. M., Gurusamy, . P. & Bhuyan, . G. (2026) Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. J. res. tradit. med, 12 (1), 158-164. doi:10.5455/jrtm.2026-308189

Turabian Style

Sathya, Krishna Rao, Indu Sabu, Banamali Das, Mrutymjaya Rao Meda, Madan Mohan Padhi, Pragatheeswari Gurusamy, and Gurucharan Bhuyan. 2026. Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 12 (1), 158-164. doi:10.5455/jrtm.2026-308189

Chicago Style

Sathya, Krishna Rao, Indu Sabu, Banamali Das, Mrutymjaya Rao Meda, Madan Mohan Padhi, Pragatheeswari Gurusamy, and Gurucharan Bhuyan. "Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 12 (2026), 158-164. doi:10.5455/jrtm.2026-308189

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Sathya, K. R., Sabu, . I., Das, . B., Meda, . M. R., Padhi, . M. M., Gurusamy, . P. & Bhuyan, . G. (2026) Comparative efficacy of Haridrakhanda versus Haridrakhanda with Anutailanasya in Allergic Rhinitis: A randomised controlled parallel study protocol. JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE, 12 (1), 158-164. doi:10.5455/jrtm.2026-308189

Submit Paper

Online Manuscript System

Track Status

Follow Review Process